$MOH

Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript

Molina Healthcare (MOH) reported Q3 2026 adjusted EPS of $0.89B on $10.5B premium revenue, with a 92.9% MCR. Full-year 2026 guidance remains $42B in premium revenue and at least $5.25 EPS. 2027 premium revenue is expected to be at least $45B, with known rate increases averaging 6% and medical cost trend projected at 5.5%-6%. The company reaffirmed its Medicaid and Medicare strategies, including exiting the MAPD business and reducing Marketplace footprint.

Original reporting
Published Oct 22, 2026, 5:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 5:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Molina Healthcare (MOH) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$MOHNeutralHigh
01

Why it matters

The reaffirmed guidance and detailed Medicaid rate outlook give traders fresh data to price the stock.

02

Market read

First report of Q3 results and FY guidance provides actionable insight for traders.

03

What to watch

Potential upside from delayed Medicaid contracts in GA and TX if resolved earlier than anticipated.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Molina Healthcare provided its Q3 earnings call transcript, reaffirming full-year guidance and outlining 2027 outlook.

Company-level read

Ticker impact

$MOHNeutralHigh confidence
Context

Q3 2026 earnings call disclosed adjusted EPS of $0.89B, $10.5B premium revenue and reaffirmed FY 2026 guidance of $42B revenue and $5.25 EPS.

Expected impact

likely slight downside as market prices in unchanged guidance amid cost concerns

Evidence & confidence

Earnings and guidance are primary disclosures; investors may react conservatively.

Market effects

Healthcare insurance sector may see modest pressure as Molina's guidance suggests stable but not accelerating growth.

U.S. market participants focused on Medicaid and Medicare trends may adjust expectations for similar insurers.

Limited global impact; primarily relevant to U.S. health insurance investors.

Counterpoint

If Medicaid rate increases exceed expectations, the stock could rally on upside margin potential.

Key entities

  • Molina Healthcare

    U.S.-listed health insurer (ticker MOH).

  • Joe Zubretsky

    CEO of Molina Healthcare delivering the earnings call.

Related articles

$MOHHighAI 8/10

Molina Healthcare Q3 Earnings Call Highlights

Molina Healthcare (MOH) expects its legacy Medicaid business to achieve a 1.6% pretax margin in 2026, with a 6% rate increase projected for 2027. The company anticipates a 6% membership decline in 2027 due to federal work requirements. Its Florida CMS contract, started in Q3, is expected to create a $1.50-per-share earnings drag in 2026. Molina's 2027 premium revenue is projected at $45 billion, down from $46.5 billion. The company's Medicare and Marketplace segments show mixed performance.

$MOHHighAI 8/10

Molina: Q3 Earnings Snapshot

Molina Healthcare (MOH) reported Q3 net income of $38M, or 73 cents per share, beating analyst estimates of 72 cents. Revenue was $11.08B, exceeding expectations of $10.93B. The company forecasts full-year earnings of $5.25 per share and revenue of $42B.

$MOHHighAI 8/10

Molina Healthcare’s (NYSE:MOH) Q3 2026 sales top estimates

Molina Healthcare (MOH) reported Q3 2026 revenue of $11.08B, down 3.4% YoY but exceeding estimates by 2%. Adjusted operating margin was 1.2%, and EPS was $0.89, down from last year but beating estimates. Analysts project 9% revenue growth and 311% EPS growth over the next 12 months. The stock fell 4.1% post-results.

$MOHHighAI 8/10

Molina Healthcare falls 4% on challenging environment, despite beating third quarter estimates

Molina Healthcare (NYSE:MOH) reported Q3 earnings of $0.89 per share, beating estimates by $0.10, with revenue at $11.08B, down 4% YoY. Shares fell 4.6% due to margin pressures and a challenging environment. The company reaffirmed its 2026 guidance of at least $5.25 per share. Membership and premium revenue declined due to lower Medicaid and Marketplace enrollment.